Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Journey Medical Corporation (DERM) vs Organogenesis (ORGO)

Journey Medical Corporation and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Organogenesis is the larger, with a market value of $207.1M against $178.4M — 1.2× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against 6.50%. Journey Medical Corporation has the higher net margin (−8.95% vs −22.2%) and the higher return on invested capital (−5.89% vs −20.0%). Across the 19 metrics below, Organogenesis leads on 12 and Journey Medical Corporation on 7.

Valuation

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.48 0.39 2.25
P/B 5.26 1.22 1.90
Price to free cash flow n/m 8.64 16.54
EV/EBITDA 96.75 n/m 12.29
EV/Sales 2.47 0.33 2.56
Earnings yield (3.58%) (60.71%) (2.99%)
Free cash flow yield (13.32%) 11.57% 0.00%

Profitability

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Gross margin 65.45% 70.35% 53.94%
Operating margin (4.41%) (7.84%) 0.00%
Net margin (8.95%) (22.23%) 0.00%
Free cash flow margin (10.99%) 4.56% 0.00%
Return on equity (23.77%) (53.31%) (0.40%)
Return on assets (6.80%) (23.44%) (3.32%)
Return on invested capital (5.89%) (19.97%) 0.00%

Growth

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 20.89% 6.50% 10.01%
EPS growth (last fiscal year) 34.72% 1,600.00% —
Revenue growth, 5-year CAGR 6.79% 10.77% 6.74%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Debt to equity 0.79 0.07 0.05
Current ratio 1.59 3.52 2.31
Net debt to EBITDA (0.35) (1.14) 0.85

Dividend

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Market cap 178.38m 207.13m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack